Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-25 of 392 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC.
Carlisle JW, Pentz RD, Ramalingam SS
J Thorac Oncol, 19(11):1509-1511, 01 Nov 2024
Cited by: 0 articles | PMID: 39510705
Add to export list
The pro-oncogenic noncanonical activity of a RAS•GTP:RanGAP1 complex facilitates nuclear protein export.
Tripathi BK, Hirsh NH, Qian X, Durkin ME, Wang D, Papageorge AG, Lake R, Evrard YA, Marcus AI, Ramalingam SS, Dasso M, Vousden KH, Doroshow JH, Walters KJ, Lowy DR
Nat Cancer, 11 Nov 2024
Cited by: 0 articles | PMID: 39528835
Add to export list
Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer.
Koo J, Seong CS, Parker RE, Herrera A, Dwivedi B, Arthur RA, Dinasarapu AR, Johnston HR, Claussen H, Tucker-Burden C, Ramalingam SS, Fu H, Zhou W, Marcus AI, Gilbert-Ross M
Cancer Res, 84(22):3761-3771, 01 Nov 2024
Cited by: 0 articles | PMID: 39207369 | PMCID: PMC11565166
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The MARIPOSA trials - implications for the treatment of EGFR-mutant NSCLC.
Ardeshir-Larijani F, Ramalingam SS
Nat Rev Clin Oncol, 21(11):767-768, 01 Nov 2024
Cited by: 0 articles | PMID: 39160242
Add to export list
Spatially resolved subcellular protein-protein interactomics in drug-perturbed lung-cancer cultures and tissues.
Cai S, Hu T, Venkataraman A, Rivera Moctezuma FG, Ozturk E, Zhang N, Wang M, Zvidzai T, Das S, Pillai A, Schneider F, Ramalingam SS, Oh YT, Sun SY, Coskun AF
Nat Biomed Eng, 30 Oct 2024
Cited by: 0 articles | PMID: 39478233
Add to export list
Plain language summary: tarlatamab for patients with previously treated small cell lung cancer.
Ahn MJ, Cho BC, Felip E, Korantzis I, Ohashi K, Majem M, Juan-Vidal O, Handzhiev S, Izumi H, Lee JS, Dziadziuszko R, Wolf J, Blackhall F, Reck M, Alvarez JB, Hummel HD, Dingemans AC, Sands J, Akamatsu H, [...] Paz-Ares L
Future Oncol, 1-10, 12 Nov 2024
Cited by: 0 articles | PMID: 39530627
Add to export list
Long-Term Survival Outcomes With First-Line Nivolumab Plus Ipilimumab-Based Treatment in Patients With Metastatic NSCLC and Tumor Programmed Death-Ligand 1 Lower Than 1%: A Pooled Analysis.
Peters S, Paz-Ares LG, Reck M, Carbone DP, Brahmer JR, Borghaei H, Lu S, O'Byrne KJ, John T, Ciuleanu TE, Schenker M, Bernabe Caro R, Nishio M, Cobo M, Lee JS, Zurawski B, Pluzanski A, Aoyama T, Tschaika M, [...] Ramalingam SS
J Thorac Oncol, S1556-0864(24)02355-4, 04 Oct 2024
Cited by: 0 articles | PMID: 39369790
Add to export list
Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA study.
Lu S, Ahn MJ, Reungwetwattana T, Özgüroğlu M, Kato T, Yang JC, Huang M, Fujiki F, Inoue T, Quang LV, Sriuranpong V, Vicente D, Fuentes C, Chaudhry AA, Poole L, Armenteros Monterroso E, Rukazenkov Y, van der Gronde T, Ramalingam SS
Ann Oncol, S0923-7534(24)03823-7, 11 Sep 2024
Cited by: 0 articles | PMID: 39289145
Add to export list
Recent treatment patterns and real-world survival following first-line anti-PD-L1 treatment for extensive-stage small cell lung cancer.
Shaw J, Pundole X, Balasubramanian A, Anderson ES, Pastel M, Bebb DG, Jiang T, Martinez P, Ramalingam SS, Borghaei H
Oncologist, oyae234, 30 Sep 2024
Cited by: 0 articles | PMID: 39349396
Add to export list
Inhibition of hTERT/telomerase/telomere mediates therapeutic efficacy of osimertinib in EGFR mutant lung cancer.
Chen Z, Vallega KA, Wang D, Quan Z, Fan S, Wang Q, Leal T, Ramalingam SS, Sun SY
J Exp Med, 221(11):e20240435, 19 Sep 2024
Cited by: 0 articles | PMID: 39297884
Add to export list
The association of azole antifungals with overall survival in patients with non-small cell lung cancer receiving immune checkpoint inhibitors.
Sebastian NT, Stokes WA, Behera M, Jiang R, Gutman DA, Huang Z, Burns A, Sukhatme V, Lowe MC, Ramalingam SS, Sukhatme VP, Moghanaki D
Oncologist, oyae262, 25 Sep 2024
Cited by: 0 articles | PMID: 39321212
Add to export list
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC. Reply.
Lu S, Ramalingam SS
N Engl J Med, 391(16):1555-1556, 01 Oct 2024
Cited by: 0 articles | PMID: 39442050
Add to export list
Encorafenib plus binimetinib for BRAF V600E-mutant metastatic NSCLC: clinical implications of the phase 2 PHAROS study.
Ramalingam SS, Carlisle JW
Future Oncol, 20(33):2503-2508, 03 Sep 2024
Cited by: 0 articles | PMID: 39225598 | PMCID: PMC11537293
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Characteristics of Lung Cancer Patients With Asymptomatic or Undiagnosed SARS-CoV-2 Infections.
Somisetty M, Mack PC, Hsu CY, Huang Y, Gomez JE, Rodilla AM, Cagan J, Tavolacci SC, Carreño JM, Brody R, Moore AC, King JC, Rohs NC, Rolfo C, Bunn PA, Minna JD, Bhalla S, Krammer F, García-Sastre A, [...] Gerber DE
Clin Lung Cancer, 25(7):612-618, 20 Jul 2024
Cited by: 0 articles | PMID: 39122606
Add to export list
Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histology.
Marks JA, Gandhi N, Halmos B, Marmarelis ME, Yeon Kim S, Bazhenova L, Ramalingam SS, Xiu J, Walker P, Oberley MJ, Ma PC, Liu SV
Lung Cancer, 196:107935, 02 Sep 2024
Cited by: 0 articles | PMID: 39241297
Add to export list
Targeting Transient Receptor Potential Melastatin-2 (TRPM2) Enhances Therapeutic Efficacy of Third Generation EGFR Inhibitors against EGFR Mutant Lung Cancer.
Chen Z, Vallega KA, Boda VK, Quan Z, Wang D, Fan S, Wang Q, Ramalingam SS, Li W, Sun SY
Adv Sci (Weinh), 11(35):e2310126, 23 Jul 2024
Cited by: 1 article | PMID: 39044361 | PMCID: PMC11425210
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Longitudinal Analyses of Circulating Tumor DNA for the Detection of EGFR Mutation-Positive Advanced NSCLC Progression During Treatment: Data From FLAURA and AURA3.
Gray JE, Markovets A, Reungwetwattana T, Majem M, Nogami N, Peled N, Lee JS, Cho BC, Chewaskulyong B, John T, Han JY, Sebastian M, Todd A, Rukazenkov Y, Barrett C, Chmielecki J, Lee SM, Ramalingam SS, Hartmaier R
J Thorac Oncol, 19(11):1525-1538, 17 Jul 2024
Cited by: 0 articles | PMID: 39029876
Add to export list
Direct to Cancer: A new initiative to enhance the author experience.
Ramalingam SS, Gilman CA
Cancer, 130(20):3404-3405, 18 Jun 2024
Cited by: 0 articles | PMID: 38888937
Add to export list
Commemorating the 20th anniversary of the discovery of epidermal growth factor receptor mutation in lung cancer: Translational research at its best.
Leal TA, Ramalingam SS
Cancer, 130(11):1910-1912, 08 May 2024
Cited by: 0 articles | PMID: 38717934
Add to export list
Osimertinib after Chemoradiotherapy in Stage III <i>EGFR</i>-Mutated NSCLC.
Lu S, Kato T, Dong X, Ahn MJ, Quang LV, Soparattanapaisarn N, Inoue T, Wang CL, Huang M, Yang JC, Cobo M, Özgüroğlu M, Casarini I, Khiem DV, Sriuranpong V, Cronemberger E, Takahashi T, Runglodvatana Y, Chen M, [...] LAURA Trial Investigators
N Engl J Med, 391(7):585-597, 02 Jun 2024
Cited by: 8 articles | PMID: 38828946
Add to export list
Natural history of SCLC patients treated in third-line and beyond: A retrospective real world study.
Borghaei H, Pundole X, Sangaré L, Anderson E, Bebb DG, Jiang T, Pastel M, Carrigan G, Balasubramanian A, Martinez P, Ramalingam SS
Lung Cancer, 193:107819, 09 May 2024
Cited by: 0 articles | PMID: 38865854
Add to export list
Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 Trial.
Solomon BJ, Dagogo-Jack I, Lee SH, Boyer MJ, Ramalingam SS, Carcereny E, Felip E, Han JY, Hida T, Hughes BGM, Kim SW, Nishio M, Seto T, Okamoto T, Zhang X, Martini JF, Wang E, De Beukelaer S, Bauer TM
JTO Clin Res Rep, 5(7):100685, 16 May 2024
Cited by: 8 articles | PMID: 39034968 | PMCID: PMC11260014
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade.
Mariniello A, Nasti TH, Chang DY, Hashimoto M, Malik S, McManus DT, Lee J, McGuire DJ, Cardenas MA, Umana P, Nicolini V, Antia R, Saha A, Buchwald Z, Kissick H, Ghorani E, Novello S, Sangiolo D, Scagliotti GV, [...] Ahmed R
Clin Cancer Res, 30(9):1833-1845, 01 May 2024
Cited by: 3 articles | PMID: 37992307 | PMCID: PMC11061601
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell Lung Cancer.
Gerber DE, Wang Y, Ramalingam SS, Bhalla S, Sun Z, Borghaei H, Brahmer JR, Schiller JH
Oncologist, 29(4):342-349, 01 Apr 2024
Cited by: 0 articles | PMID: 38207008 | PMCID: PMC10994259
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
DNA topoisomerase II inhibition potentiates osimertinib's therapeutic efficacy in EGFR-mutant non-small cell lung cancer models.
Chen Z, Vallega KA, Wang D, Quan Z, Fan S, Wang Q, Leal T, Ramalingam SS, Sun SY
J Clin Invest, 134(10):e172716, 07 Mar 2024
Cited by: 2 articles | PMID: 38451729 | PMCID: PMC11093598
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 392 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Partnerships & funding